Our data indicate that, through their interaction at postsynaptic sites, Shank3 and δ-Catenin contribute to a synaptic signalling pathway which is disrupted in ASD and other neurodevelopmental disorders. This evidence concerns the gene SHANK3 and neurodevelopmental disorder.